Characteristic | No hypertension (n = 80) | History of hypertension (n = 153) | p value |
---|---|---|---|
Age, median (IQR), year | 62.5 (50.6–78.0) | 74.5 (63.4–82.6) | .01 |
Body mass index, median (IQR), kg/m2 | 25.0 (21.2–28.7) | 28.0 (23.3–33.6) | .01 |
Male sex, No. (%) | 45 (56.3) | 83 (54.2) | .78 |
Pre-admission MAP, median (IQR), mmHga | 77.3 (72.1–87.3) | 81.3 (75.0–90.5) | .13 |
Post-resuscitation MAP, median (IQR), mmHgb | 68.0 (62.2–76.5) | 68.0 (62.0–74.4) | .98 |
ΔMAP, median (IQR), mmHgc | 11.3 (3.0–17.9) | 12.7 (4.0–21.0) | .18 |
Acute kidney injury, No. (%) | 45 (56.3) | 115 (75.2) | .01 |
Stage 1 | 25 (34.3) | 48 (65.8) | |
Stage 2 | 12 (22.2) | 42 (77.8) | |
Stage 3 | 8 (24.2) | 25 (75.8) | |
Charlson comorbidity index, median (IQR) | 5 (3–7) | 8 (6–11) | .01 |
APACHE III score, 24 h, median (IQR) | 71 (61.3–88.8) | 86 (69.5–103) | .01 |
SOFA score, day 1, median (IQR) | 6 (4–9) | 7 (4–10) | .40 |
Any inotropic agent, No. (%) | 8 (10.0) | 24 (15.7) | .32 |
Any vasoactive agent, No. (%) | 46 (57.5) | 94 (61.4) | .58 |
Fluid balance, median (IQR), mL | 6419 (3334–8953) | 6073 (2398–10,225) | .43 |